Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C32H40N2O |
| Molecular Weight | 468.6728 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1CN[C@H]2C3CCN(CC3)[C@H]2C(C4=CC=CC=C4)C5=CC=CC=C5)C(C)(C)C
InChI
InChIKey=OMPCVMLFFSQFIX-CONSDPRKSA-N
InChI=1S/C32H40N2O/c1-32(2,3)27-15-16-28(35-4)26(21-27)22-33-30-25-17-19-34(20-18-25)31(30)29(23-11-7-5-8-12-23)24-13-9-6-10-14-24/h5-16,21,25,29-31,33H,17-20,22H2,1-4H3/t30-,31-/m0/s1
| Molecular Formula | C32H40N2O |
| Molecular Weight | 468.6728 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:25:30 UTC 2023
by
admin
on
Fri Dec 15 16:25:30 UTC 2023
|
| Record UNII |
4XE2T9H4DH
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 520.1315
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
||
|
WHO-VATC |
QA04AD90
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
||
|
CFR |
21 CFR 522.1315
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
||
|
NCI_THESAURUS |
C267
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4XE2T9H4DH
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY | |||
|
C81500
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY | |||
|
CHEMBL2111099
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY | |||
|
C518176
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY | |||
|
715869
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY | RxNorm | ||
|
147116-67-4
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY | |||
|
300000023688
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY | |||
|
DTXSID1057874
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY | |||
|
204108
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY | |||
|
MAROPITANT
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY | |||
|
m7089
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY | Merck Index | ||
|
4XE2T9H4DH
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY | |||
|
8421
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY | |||
|
DB11427
Created by
admin on Fri Dec 15 16:25:31 UTC 2023 , Edited by admin on Fri Dec 15 16:25:31 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
